NAFLD and NASH in postmenopausal women: implications for diagnosis and treatment

JK DiStefano - Endocrinology, 2020 - academic.oup.com
Nonalcoholic fatty liver disease (NAFLD) prevalence in women is increasing worldwide.
Women of reproductive age have lower rates of NAFLD compared with men; however, this …

NAFLD as a sexual dimorphic disease: role of gender and reproductive status in the development and progression of nonalcoholic fatty liver disease and inherent …

S Ballestri, F Nascimbeni, E Baldelli, A Marrazzo… - Advances in …, 2017 - Springer
Nonalcoholic fatty liver disease (NAFLD) spans steatosis through nonalcoholic
steatohepatis, cirrhosis, and hepatocellular carcinoma (HCC) associated with striking …

[HTML][HTML] Estrogen as a key regulator of energy homeostasis and metabolic health

F Mahboobifard, MH Pourgholami, M Jorjani… - Biomedicine & …, 2022 - Elsevier
Over the last two decades, it has become evident that estrogens preserve the integrity of
energy homeostasis at central and peripheral levels. Estrogen deficiency, such as that …

Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences

P Anagnostis, BC Tarlatzis, RP Kauffman - Metabolism, 2018 - Elsevier
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women during
their reproductive ages, associated with a plethora of cardiometabolic consequences, with …

Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline

RS Legro, SA Arslanian, DA Ehrmann… - The Journal of …, 2013 - academic.oup.com
Objective: The aim was to formulate practice guidelines for the diagnosis and treatment of
polycystic ovary syndrome (PCOS). Participants: An Endocrine Society-appointed Task …

Nonalcoholic fatty liver disease in adults: current concepts in etiology, outcomes, and management

T Marjot, A Moolla, JF Cobbold, L Hodson… - Endocrine …, 2020 - academic.oup.com
Nonalcoholic fatty liver disease (NAFLD) is a spectrum of disease, extending from simple
steatosis to inflammation and fibrosis with a significant risk for the development of cirrhosis. It …

Non-alcoholic fatty liver disease, obesity and the metabolic syndrome

P Dietrich, C Hellerbrand - Best practice & research Clinical …, 2014 - Elsevier
Nonalcoholic fatty liver disease (NAFLD) is now recognized as the most common cause of
chronic liver disease worldwide. Its prevalence has increased to more than 30% of adults in …

Prevalence and severity of nonalcoholic fatty liver disease in non-obese patients: a population study using proton-magnetic resonance spectroscopy

JL Wei, JCF Leung, TCW Loong… - Official journal of the …, 2015 - journals.lww.com
OBJECTIVES: Some studies suggest that non-obese patients with nonalcoholic fatty liver
disease (NAFLD) may have more severe disease. We aim to study the epidemiology and …

Sex differences in muscle wasting

LJ Anderson, H Liu, JM Garcia - Sex and gender factors affecting …, 2017 - Springer
With aging and other muscle wasting diseases, men and women undergo similar
pathological changes in skeletal muscle: increased inflammation, enhanced oxidative …

Targeting nonalcoholic fatty liver disease via gut microbiome-centered therapies

M Koning, H Herrema, M Nieuwdorp… - Gut Microbes, 2023 - Taylor & Francis
Humans possess abundant amounts of microorganisms, including bacteria, fungi, viruses,
and archaea, in their gut. Patients with nonalcoholic fatty liver disease (NAFLD) exhibit …